CROSS HERB
SEC insider (Form 3/4/5 filer). CIK 0001230721. Chief Financial Officer at Jasper Therapeutics, Inc. (JSPR). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in REDWOOD CITY, CA.
Companies CROSS HERB has filed insider reports for
- Jasper Therapeutics, Inc. (JSPR): Officer, Chief Financial Officer
CROSS HERB
CIK: 0001230721
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
JSPR
Jasper Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 2, 2026JSPR
Jasper Therapeutics, Inc.
AwardDirectStock Option (right to buy)
90K shares- - Jun 4, 2025JSPR
Jasper Therapeutics, Inc.
AwardDirectStock Option (right to buy)
90K shares- - Feb 13, 2025JSPR
Jasper Therapeutics, Inc.
AwardDirectStock Option (right to buy)
50K shares-
1-3 of 3 transactions